Publications

Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapy

Tan, W. C. C., Nerurkar, S. N., Cai, H. Y., Ng, H. H. M., Wu, D., Wee, Y. T. F., … & Lim, T. K. H. (2020). Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapy. Cancer Communications, 40(4), 135-153.

Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapy Read More »

Cancer Cell–Intrinsic Expression of MHC Class II Regulates the Immune Microenvironment and Response to Anti–PD-1 Therapy in Lung Adenocarcinoma

Johnson, A. M., Bullock, B. L., Neuwelt, A. J., Poczobutt, J. M., Kaspar, R. E., Li, H. Y., … & Schenk, E. L. (2020). Cancer Cell–Intrinsic Expression of MHC Class II Regulates the Immune Microenvironment and Response to Anti–PD-1 Therapy in Lung Adenocarcinoma. The Journal of Immunology, 204(8), 2295-2307.

Cancer Cell–Intrinsic Expression of MHC Class II Regulates the Immune Microenvironment and Response to Anti–PD-1 Therapy in Lung Adenocarcinoma Read More »

The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling

Mohamed, E., Sierra, R. A., Trillo-Tinoco, J., Cao, Y., Innamarato, P., Payne, K. K., … & Biswas, S. (2020). The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling. Immunity, 52(4), 668-682.

The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling Read More »

Temporal and spatial modulation of the tumor and systemic immune response in the murine Gl261 glioma model

McKelvey, K. J., Hudson, A. L., Prasanna Kumar, R., Wilmott, J. S., Attrill, G. H., Long, G. V., … & Howell, V. M. (2020). Temporal and spatial modulation of the tumor and systemic immune response in the murine Gl261 glioma model. Plos one, 15(4), e0226444.

Temporal and spatial modulation of the tumor and systemic immune response in the murine Gl261 glioma model Read More »

In situ multiplex immunofluorescence analysis of the inflammatory burden in kidney allograft rejection: A new tool to characterize the alloimmune response

Calvani, J., Terada, M., Lesaffre, C., Eloudzeri, M., Lamarthée, B., Burger, C., … & Loupy, A. (2020). In situ multiplex immunofluorescence analysis of the inflammatory burden in kidney allograft rejection: A new tool to characterize the alloimmune response. American Journal of Transplantation, 20(4), 942-953.

In situ multiplex immunofluorescence analysis of the inflammatory burden in kidney allograft rejection: A new tool to characterize the alloimmune response Read More »

In Situ Immune Profiling of Heart Transplant Biopsies Improves Diagnostic Accuracy and Rejection Risk Stratification

Peyster, E. G., Wang, C., Ishola, F., Remeniuk, B., Hoyt, C., Feldman, M. D., & Margulies, K. B. (2020). In situ immune profiling of heart transplant biopsies improves diagnostic accuracy and rejection risk stratification. JACC: Basic to Translational Science, 5(4), 328-340.

In Situ Immune Profiling of Heart Transplant Biopsies Improves Diagnostic Accuracy and Rejection Risk Stratification Read More »

Perivascular Neuropilin‐1 expression is an independent marker of improved survival in renal cell carcinoma

Morin, E., Lindskog, C., Johansson, M., Egevad, L., Sandström, P., Harmenberg, U., … & Sjöberg, E. (2020). Perivascular Neuropilin‐1 expression is an independent marker of improved survival in renal cell carcinoma. The Journal of pathology, 250(4), 387-396.

Perivascular Neuropilin‐1 expression is an independent marker of improved survival in renal cell carcinoma Read More »

Pre-existing inflammatory immune microenvironment predicts the clinical response of vulvar high-grade squamous intraepithelial lesions to therapeutic HPV16 vaccination

Abdulrahman, Z., de Miranda, N., van Esch, E., de Vos van Steenwijk, P. J., Nijman, H. W., J P Welters, M., van Poelgeest, M., & van der Burg, S. H. (2020). Pre-existing inflammatory immune microenvironment predicts the clinical response of vulvar high-grade squamous intraepithelial lesions to therapeutic HPV16 vaccination. Journal for immunotherapy of cancer, 8(1), e000563. https://doi.org/10.1136/jitc-2020-000563

Pre-existing inflammatory immune microenvironment predicts the clinical response of vulvar high-grade squamous intraepithelial lesions to therapeutic HPV16 vaccination Read More »